Skip to content
2000
Volume 9, Issue 9
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The neutralization of VEGF is the current treatment of choice for age-related macular degeneration. Current approaches include anti-VEGF-antibodies and -Fab Fragments, aptamers, soluble receptors (Traps) and siRNA. The molecular properties of VEGF and its antagonists are reviewed and the pathways of action of these substances are discussed.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955709788922665
2009-08-01
2024-11-15
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955709788922665
Loading

  • Article Type:
    Research Article
Keyword(s): AMD; lucentis; pegaptanib; ranibizumab; VEGF; VEGF-trap
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test